WCM
PYXS icon

Winthrop Capital Management’s Pyxis Oncology PYXS Stock Holding History

Winthrop Capital Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18K Hold
6,000
– – ﹤0.01% 215
2026
Q1 		$9K Hold
6,000
– – ﹤0.01% 242
2025
Q4 		$7K Hold
6,000
– – ﹤0.01% 248
2025
Q3 		$13K Hold
6,000
– – ﹤0.01% 217
2025
Q2 		$7K Hold
6,000
– – ﹤0.01% 234
2025
Q1 		$6K Hold
6,000
– – ﹤0.01% 218
2024
Q4 		$9K Buy
+6,000
New +$17.3K ﹤0.01% 223

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winthrop Capital Management's PYXS Position: Q2 2026 in Review

Winthrop Capital Management held its Pyxis Oncology (PYXS) position steady in Q2 2026 at 6,000 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #215.

Winthrop Capital Management first reported a position in PYXS in Q4 2024 and has held it in 7 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Winthrop Capital Management held 6,000 shares of Pyxis Oncology worth $18K as of Q2 2026.
  • Winthrop Capital Management left its Pyxis Oncology share count unchanged in Q2 2026.
  • Pyxis Oncology made up ﹤0.01% of Winthrop Capital Management's portfolio in Q2 2026, its #215 holding.
  • Winthrop Capital Management first reported a position in Pyxis Oncology in Q4 2024 and has held it in 7 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.